As of 3:51pm ET
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +141.76% increase from the last price of 4.55.
The current consensus among 2 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.